{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:54:04Z","timestamp":1791176044048,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T00:00:00Z","timestamp":1340841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2458-12-488","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T14:14:48Z","timestamp":1340892888000},"source":"Crossref","is-referenced-by-count":18,"title":["Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial"],"prefix":"10.1186","volume":"12","author":[{"name":"and the ANRS Methaville Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Aubertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Desenclos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Spire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia M","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,28]]},"reference":[{"key":"4683_CR1","doi-asserted-by":"crossref","unstructured":"Mattick RP, Kimber J, Breen C, Davoli M: Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008, CD002207-2","DOI":"10.1002\/14651858.CD002207.pub3"},{"issue":"1 Pt 1","key":"4683_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.gcb.2008.11.009","volume":"33","author":"L Michel","year":"2009","unstructured":"Michel L, Roux P, Cohen J, Carrieri MP: A French prospective observational study of the treatment of chronic hepatitis C in drug abusers: a commentary. Gastroenterol Clin Biol. 2009, 33 (1 Pt 1): 15-16. author reply 16\u201317.","journal-title":"Gastroenterol Clin Biol"},{"issue":"Suppl 4","key":"4683_CR3","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1086\/508184","volume":"43","author":"MP Carrieri","year":"2006","unstructured":"Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE: Buprenorphine use: the international experience. Clin Infect Dis. 2006, 43 (Suppl 4): S197-S215.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4683_CR4","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","volume":"100","author":"J Emmanuelli","year":"2005","unstructured":"Emmanuelli J, Desenclos JC: Harm reduction interventions, behaviours and associated health outcomes in France, 1996\u20132003. Addiction. 2005, 100 (11): 1690-1700. 10.1111\/j.1360-0443.2005.01271.x.","journal-title":"Addiction"},{"issue":"12","key":"4683_CR5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.addbeh.2008.07.018","volume":"33","author":"P Roux","year":"2008","unstructured":"Roux P, Villes V, Bry D, Spire B, Feroni I, Marcellin F, Carrieri MP: Buprenorphine sniffing as a response to inadequate care in substituted patients: results from the Subazur survey in south-eastern France. Addict Behav. 2008, 33 (12): 1625-1629. 10.1016\/j.addbeh.2008.07.018.","journal-title":"Addict Behav"},{"issue":"2","key":"4683_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0376-8716(02)00312-5","volume":"69","author":"G Vidal-Trecan","year":"2003","unstructured":"Vidal-Trecan G, Varescon I, Nabet N, Boissonnas A: Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. Drug Alcohol Depend. 2003, 69 (2): 175-181. 10.1016\/S0376-8716(02)00312-5.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"4683_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1360-0443.2003.00296.x","volume":"98","author":"M Gossop","year":"2003","unstructured":"Gossop M, Marsden J, Stewart D, Kidd T: The National Treatment Outcome Research Study (NTORS): 4\u20135 year follow-up results. Addiction. 2003, 98 (3): 291-303. 10.1046\/j.1360-0443.2003.00296.x.","journal-title":"Addiction"},{"issue":"3","key":"4683_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0740-5472(03)00130-2","volume":"25","author":"RL Hubbard","year":"2003","unstructured":"Hubbard RL, Craddock SG, Anderson J: Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003, 25 (3): 125-134. 10.1016\/S0740-5472(03)00130-2.","journal-title":"J Subst Abuse Treat"},{"issue":"438","key":"4683_CR9","first-page":"31","volume":"49","author":"M Gossop","year":"1999","unstructured":"Gossop M, Marsden J, Stewart D, Lehmann P, Strang J: Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study. Br J Gen Pract. 1999, 49 (438): 31-34.","journal-title":"Br J Gen Pract"},{"issue":"10","key":"4683_CR10","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/jama.283.10.1343","volume":"283","author":"M Weinrich","year":"2000","unstructured":"Weinrich M, Stuart M: Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy. JAMA. 2000, 283 (10): 1343-1348. 10.1001\/jama.283.10.1343.","journal-title":"JAMA"},{"issue":"14","key":"4683_CR11","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1001\/jama.286.14.1724","volume":"286","author":"DA Fiellin","year":"2001","unstructured":"Fiellin DA, O\u2019Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS: Methadone maintenance in primary care: a randomized controlled trial. JAMA. 2001, 286 (14): 1724-1731. 10.1001\/jama.286.14.1724.","journal-title":"JAMA"},{"issue":"11","key":"4683_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","volume":"281","author":"EC Strain","year":"1999","unstructured":"Strain EC, Bigelow GE, Liebson IA, Stitzer ML: Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA. 1999, 281 (11): 1000-1005. 10.1001\/jama.281.11.1000.","journal-title":"JAMA"},{"issue":"1","key":"4683_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","volume":"87","author":"T Kerr","year":"2007","unstructured":"Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, Wood E: Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007, 87 (1): 39-45. 10.1016\/j.drugalcdep.2006.07.009.","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 20","key":"4683_CR14","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 59 (Suppl 20): 22-33. quiz 34\u201357.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"4683_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10550880802122620","volume":"27","author":"B Brands","year":"2008","unstructured":"Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S: The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis. 2008, 27 (3): 37-48. 10.1080\/10550880802122620.","journal-title":"J Addict Dis"},{"key":"4683_CR16","volume-title":"Methadone-Drug Interactions","author":"SB Leavitt","year":"2005","unstructured":"Leavitt SB: Methadone-Drug Interactions. 2005, Forum: In Addiction Treatment"},{"issue":"1","key":"4683_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11916-009-0006-0","volume":"13","author":"JA Trafton","year":"2009","unstructured":"Trafton JA, Ramani A: Methadone: a new old drug with promises and pitfalls. Curr Pain Headache Rep. 2009, 13 (1): 24-30. 10.1007\/s11916-009-0006-0.","journal-title":"Curr Pain Headache Rep"},{"key":"4683_CR18","unstructured":"Groves RM, Mathiowetz NA: Chapter V. A comparison of CATI and non-CATI questionnaires. Vital and health statistics. 1987, 33-39. 106"},{"issue":"5","key":"4683_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1360-0443.1992.tb02719.x","volume":"87","author":"S Darke","year":"1992","unstructured":"Darke S, Hall W, Wodak A, Heather N, Ward J: Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992, 87 (5): 733-742. 10.1111\/j.1360-0443.1992.tb02719.x.","journal-title":"Br J Addict"},{"issue":"2","key":"4683_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1360-0443.2003.00207.x","volume":"98","author":"CL Fry","year":"2003","unstructured":"Fry CL, Lintzeris N: Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction. 2003, 98 (2): 171-178. 10.1046\/j.1360-0443.2003.00207.x.","journal-title":"Addiction"},{"key":"4683_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7517-5-12","volume":"5","author":"MA Stoove","year":"2008","unstructured":"Stoove MA, Fry CL, Lintzeris N: Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention. Harm Reduct J. 2008, 5: 12-10.1186\/1477-7517-5-12.","journal-title":"Harm Reduct J"},{"issue":"11","key":"4683_CR22","first-page":"964","volume":"18","author":"D Lucidarme","year":"1994","unstructured":"Lucidarme D, Foutrein P, Creusy C, Forzy G, Foutrein-Comes MC, Muyssen A, Bailly D, Parquet PJ, Filoche B: Prevalence of hepatitis C, B and D markers and histopathological aspects in a group of intravenous drug addicts. Gastroenterol Clin Biol. 1994, 18 (11): 964-968.","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"4683_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1017\/S095026880400247X","volume":"132","author":"D Lucidarme","year":"2004","unstructured":"Lucidarme D, Bruandet A, Ilef D, Harbonnier J, Jacob C, Decoster A, Delamare C, Cyran C, Van Hoenacker AF, Fremaux D, et al: Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiol Infect. 2004, 132 (4): 699-708. 10.1017\/S095026880400247X.","journal-title":"Epidemiol Infect"},{"key":"4683_CR24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0767399X00001590","volume":"4","author":"R Fuhrer","year":"1989","unstructured":"Fuhrer R, Rouillon F: La version fran\u00e7aise de l\u2019\u00e9chelle CES-D. Description and translation of the autoevaluation scale (in French). Psychiatrie et Psychobiologie. 1989, 4: 163-166.","journal-title":"Psychiatrie et Psychobiologie"},{"issue":"5","key":"4683_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1176\/ajp.142.5.559","volume":"142","author":"AT Beck","year":"1985","unstructured":"Beck AT, Steer RA, Kovacs M, Garrison B: Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry. 1985, 142 (5): 559-563.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"4683_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1207\/S15327752JPA8103_12","volume":"81","author":"JW Roberti","year":"2003","unstructured":"Roberti JW, Storch EA, Bravata E: Further psychometric support for the Sensation Seeking Scale\u2013Form V. J Pers Assess. 2003, 81 (3): 291-292. 10.1207\/S15327752JPA8103_12.","journal-title":"J Pers Assess"},{"issue":"2","key":"4683_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1360-0443.1999.94226910.x","volume":"94","author":"JF Etter","year":"1999","unstructured":"Etter JF, Duc TV, Perneger TV: Validity of the Fagerstrom test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction. 1999, 94 (2): 269-281. 10.1046\/j.1360-0443.1999.94226910.x.","journal-title":"Addiction"},{"issue":"6","key":"4683_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption\u2013II. Addiction. 1993, 88 (6): 791-804. 10.1111\/j.1360-0443.1993.tb02093.x.","journal-title":"Addiction"},{"issue":"6","key":"4683_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jpainsymman.2006.09.031","volume":"33","author":"J Poundja","year":"2007","unstructured":"Poundja J, Fikretoglu D, Guay S, Brunet A: Validation of the French version of the brief pain inventory in Canadian veterans suffering from traumatic stress. J Pain Symptom Manage. 2007, 33 (6): 720-726. 10.1016\/j.jpainsymman.2006.09.031.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"4683_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpainsymman.2006.01.007","volume":"32","author":"MY Smith","year":"2006","unstructured":"Smith MY, Winkel G, Egert J, Diaz-Wionczek M, DuHamel KN: Patient-physician communication in the context of persistent pain: validation of a modified version of the patients\u2019 Perceived Involvement in Care Scale. J Pain Symptom Manage. 2006, 32 (1): 71-81. 10.1016\/j.jpainsymman.2006.01.007.","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"4683_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","volume":"15","author":"M Gossop","year":"1990","unstructured":"Gossop M: The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav. 1990, 15 (5): 487-490. 10.1016\/0306-4603(90)90036-W.","journal-title":"Addict Behav"},{"issue":"3","key":"4683_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996, 34 (3): 220-233. 10.1097\/00005650-199603000-00003.","journal-title":"Med Care"},{"issue":"2","key":"4683_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S0033291704002892","volume":"35","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, et al: The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005, 35 (2): 245-256. 10.1017\/S0033291704002892.","journal-title":"Psychol Med"},{"key":"4683_CR34","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1192\/bjp.187.4.360","volume":"187","author":"BP Smyth","year":"2005","unstructured":"Smyth BP, Barry J, Lane A, Cotter M, O\u2019Neill M, Quinn C, Keenan E: In-patient treatment of opiate dependence: medium-term follow-up outcomes. Br J Psychiatry. 2005, 187: 360-365. 10.1192\/bjp.187.4.360.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"4683_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jsat.2006.11.009","volume":"33","author":"I Maremmani","year":"2007","unstructured":"Maremmani I, Pani PP, Pacini M, Perugi G: Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat. 2007, 33 (1): 91-98. 10.1016\/j.jsat.2006.11.009.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"4683_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.drugalcdep.2008.01.015","volume":"95","author":"HU Wittchen","year":"2008","unstructured":"Wittchen HU, Apelt SM, Soyka M, Gastpar M, Backmund M, Golz J, Kraus MR, Tretter F, Schafer M, Siegert J, et al: Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend. 2008, 95 (3): 245-257. 10.1016\/j.drugalcdep.2008.01.015.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"4683_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/01.qai.0000186364.27587.0e","volume":"41","author":"MP Carrieri","year":"2006","unstructured":"Carrieri MP, Leport C, Protopopescu C, Cassuto JP, Bouvet E, Peyramond D, Raffi F, Moatti JP, Chene G, Spire B: Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acquir Immune Defic Syndr. 2006, 41 (4): 477-485. 10.1097\/01.qai.0000186364.27587.0e.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4683_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11136-006-9151-7","volume":"16","author":"C Protopopescu","year":"2007","unstructured":"Protopopescu C, Marcellin F, Spire B, Preau M, Verdon R, Peyramond D, Raffi F, Chene G, Leport C, Carrieri MP: Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8). Qual Life Res. 2007, 16 (4): 577-591. 10.1007\/s11136-006-9151-7.","journal-title":"Qual Life Res"},{"issue":"3","key":"4683_CR39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5694\/j.1326-5377.1999.tb127675.x","volume":"170","author":"JR Caplehorn","year":"1999","unstructured":"Caplehorn JR, Drummer OH: Mortality associated with New South Wales methadone programs in 1994: lives lost and saved. Med J Aust. 1999, 170 (3): 104-109.","journal-title":"Med J Aust"},{"key":"4683_CR40","doi-asserted-by":"publisher","first-page":"c5475","DOI":"10.1136\/bmj.c5475","volume":"341","author":"R Cornish","year":"2010","unstructured":"Cornish R, Macleod J, Strang J, Vickerman P, Hickman M: Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. BMJ. 2010, 341: c5475-10.1136\/bmj.c5475.","journal-title":"BMJ"},{"issue":"4","key":"4683_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/pubmed\/fdl059","volume":"28","author":"OW Morgan","year":"2006","unstructured":"Morgan OW, Johnson H, Rooney C, Seagroatt V, Griffiths C: Changes to the daily pattern of methadone-related deaths in England and Wales, 1993\u20132003. J Public Health (Oxf). 2006, 28 (4): 318-323. 10.1093\/pubmed\/fdl059.","journal-title":"J Public Health (Oxf)"},{"issue":"6724","key":"4683_CR42","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/bmj.300.6724.587","volume":"300","author":"J Greenwood","year":"1990","unstructured":"Greenwood J: Creating a new drug service in Edinburgh. BMJ. 1990, 300 (6724): 587-589. 10.1136\/bmj.300.6724.587.","journal-title":"BMJ"},{"issue":"1","key":"4683_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/09595230701710852","volume":"27","author":"P Lawrinson","year":"2008","unstructured":"Lawrinson P, Roche A, Terao H, Le PP: Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists. Drug Alcohol Rev. 2008, 27 (1): 47-53. 10.1080\/09595230701710852.","journal-title":"Drug Alcohol Rev"},{"issue":"11","key":"4683_CR44","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1111\/j.1360-0443.2007.02016.x","volume":"102","author":"J Sheridan","year":"2007","unstructured":"Sheridan J, Manning V, Ridge G, Mayet S, Strang J: Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995\u20132005. Addiction. 2007, 102 (11): 1824-1830. 10.1111\/j.1360-0443.2007.02016.x.","journal-title":"Addiction"},{"issue":"12 Pt 1","key":"4683_CR45","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0755-4982(06)74906-5","volume":"35","author":"N Bonnet","year":"2006","unstructured":"Bonnet N: Pharmacy syringe exchange program for injection drug users. Presse Med. 2006, 35 (12 Pt 1): 1811-1818.","journal-title":"Presse Med"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-12-488\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T01:48:27Z","timestamp":1594345707000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-12-488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,28]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["4683"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-12-488","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,28]]},"article-number":"488"}}